José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
Lyfebulb and UnitedHealth Group have selected the 11 finalists for their innovation challenge, which will reward the most innovative solutions to help patients with inflammatory bowel disease (IBD). These contestants ... Read more
A cholesterol metabolite — a byproduct of cholesterol metabolism — triggers an abnormal immune response in inflammatory bowel disease (IBD) further aggravating such diseases, researchers found in a mouse ... Read more
Women’s concerns over taking inflammatory bowel disease (IBD) medications during their reproductive years are not being satisfactorily addressed by physicians, according to a study that analyzed relevant social media ... Read more
Patients with inflammatory bowel disease (IBD) have higher levels of inflammatory mitochondrial DNA (mtDNA) in the blood, which correlate with disease flare-ups and severity, a study reports. Researchers say these ... Read more
Treatment of pediatric inflammatory bowel disease (pIBD) with tumor necrosis factor inhibitors (TNFi) does not increase the risk for malignancy, researchers report. The study with that finding, “Risk of malignancy ... Read more
Researchers at Weill Cornell Medicine in New York suggest an impaired immune regulation of gut fungi may cause inflammatory bowel disease (IBD). The study, “CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi,” ... Read more